08/24/2026
The FDA has cleared PrecivityAD2, a single blood test designed to help health care professionals rule in or rule out an Alzheimer’s disease diagnosis, according to a press release from the test’s developer, C2N. PrecivityAD2 is the first Alzheimer’s blood test to be cleared by the FDA for symp...